(Q33846118)

29 July 2017

1 reference

title

Liver biopsies and methotrexate: a time for reconsideration? (English)

1 reference

29 July 2017

1 reference

Zachariae H

1

1 reference

29 July 2017

language of work or name

English

0 references

publication date

1 March 2000

1 reference

Journal of the American Academy of Dermatology

29 July 2017

published in

1 reference

29 July 2017

volume

42

1 reference

29 July 2017

issue

3

1 reference

29 July 2017

page(s)

531-534

1 reference

Use of methotrexate in psoriasis

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2800%2990237-8

7 January 2021

Methotrexate in psoriasis: revised guidelines

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2800%2990237-8

7 January 2021

Methotrexate in psoriasis: consensus conference

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2800%2990237-8

7 January 2021

Methotrexate hepatotoxicity in psoriatics: report of 104 patients from Nova Scotia, with analysis of risks from obesity, diabetes and alcohol consumption during long term follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2800%2990237-8

7 January 2021

Methotrexate-induced liver cirrhosis. A follow-up.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2800%2990237-8

7 January 2021

Methotrexate for rheumatoid arthritis. Suggested guidelines for monitoring liver toxicity. American College of Rheumatology

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2800%2990237-8

7 January 2021

Usefulness of the American College of Rheumatology recommendations for liver biopsy in methotrexate-treated rheumatoid arthritis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2800%2990237-8

7 January 2021

Methotrexate and histologic hepatic abnormalities: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2800%2990237-8

7 January 2021

The role of liver biopsies in psoriatic patients receiving long-term methotrexate treatment. Improvement in liver abnormalities after cessation of treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2800%2990237-8

7 January 2021

Methotrexate-induced liver cirrhosis. Clinical, histological and serological studies--a further 10-year follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2800%2990237-8

7 January 2021

Liver biopsies in psoriatics--complications and evaluation

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2800%2990237-8

7 January 2021

Liver biopsy today. The Royal Free Hospital experience

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2800%2990237-8

7 January 2021

The use of antipyrine clearance to measure liver damage in psoriatic patients receiving methotrexate

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2800%2990237-8

7 January 2021

Liver biopsy versus ultrasound in methotrexate-treated psoriasis: a decision analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2800%2990237-8

7 January 2021

A comparison of liver ultrasound with liver biopsy histology in psoriatics receiving long-term methotrexate therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2800%2990237-8

7 January 2021

Serum aminoterminal propeptide of type III procollagen in psoriasis and psoriatic arthritis: relation to liver fibrosis and arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2800%2990237-8

7 January 2021

Serum type III procollagen aminopeptide for assessing liver damage in methotrexate-treated psoriatic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2800%2990237-8

7 January 2021

The N-terminal propeptide of collagen type III in serum reflects activity and degree of fibrosis in patients with chronic liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2800%2990237-8

7 January 2021

Serum type III procollagen peptide, dynamic liver function tests and hepatic fibrosis in psoriatic patients receiving methotrexate

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2800%2990237-8

7 January 2021

Dynamic hepatic scintigraphy in the screening of psoriatic patients for methotrexate-induced hepatotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2800%2990237-8

7 January 2021

10.1016/S0190-9622(00)90237-8

Identifiers

DOI

1 reference

29 July 2017

1 reference